ENTRY       D11584            Mixture   Drug
NAME        Budesonide, glycopyrronium bromide and formoterol fumarate;
            Budesonide, glycopyrrolate and formoterol fumarate;
            Breztri (TN)
PRODUCT     BREZTRI (AstraZeneca Pharmaceuticals LP)
COMPONENT   Budesonide [DR:D00246], Glycopyrrolate [DR:D00540], (Formoterol fumarate hydrate [DR:D05277] | Formoterol fumarate [DR:D01373])
REMARK      Therapeutic category: 2290
            ATC code: R03AL11
            Product: D11584<JP/US>
EFFICACY    Bronchodilator
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03A ADRENERGICS, INHALANTS
                R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
                 R03AL11 Formoterol, glycopyrronium bromide and budesonide
                  D11584  Budesonide, glycopyrronium bromide and formoterol fumarate &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Bronchodilator Combinations
               Budesonide/ Glycopyrrolate/ Formoterol Fumarate
                D11584  Budesonide, glycopyrronium bromide and formoterol fumarate
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               229  Miscellaneous
                2290  Miscellaneous
                 D11584  Budesonide, glycopyrronium bromide and formoterol fumarate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11584
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11584
DBLINKS     PubChem: 384585559
///
